title: In vivo comparison of harmine efficacy against psychostimulants: preferential inhibition of the cocaine response through a glutamatergic mechanism.
abstract: Harmine is a β-carboline compound that targets glutamatergic, monoaminergic, and GABAergic pathways underlying drug addiction. We compared the efficacy of harmine against different psychoactive drugs using an invertebrate (planarian) assay designed to quantify 'C-shape' responses. Harmine itself (0.01-10 μM) did not produce C-shapes. However, when applied over the same concentration range, harmine significantly inhibited C-shapes elicited by cocaine, with a concentration of 0.1 μM producing almost 90% inhibition. Consistent with its putative actions, harmine produced a similar, though less efficacious, inhibition of C-shapes elicited by the substituted amphetamines methamphetamine and mephedrone (4-methylmethcathinone) but was much less effective against nicotine. When tested in the presence of the glutamate transporter inhibitor dihydrokainate (DHK) (0.1, 1 μM), harmine (0.1 μM) efficacy against cocaine-induced C-shapes was significantly reduced. Harmine also attenuated C-shapes elicited by N-methyl-d-aspartate (NMDA) and by glutamate itself. The present data suggest that harmine displays preferential efficacy against different addictive substances (cocaine>amphetamines>nicotine) and, at least for cocaine, is dependent on the glutamate system.
authors.affiliation: Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, PA, USA.
authors.forename: Suzan
authors.initials: S
authors.lastname: Owaisat
authors.forename: Robert B
authors.initials: RB
authors.lastname: Raffa
authors.forename: Scott M
authors.initials: SM
authors.lastname: Rawls
mesh_terms: D000662:Amphetamines / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D003042:Cocaine / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D018698:Glutamic Acid / Q000502:physiology*; D006247:Harmine / Q000494:pharmacology*; D007266:Inhibition, Psychological; D007608:Kainic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D009538:Nicotine / Q000494:pharmacology; D018733:Nicotinic Antagonists / Q000494:pharmacology; D010932:Planarians; D011619:Psychotropic Drugs / Q000037:antagonists & inhibitors* / Q000494:pharmacology*
chemical_list: D000662:Amphetamines; D018691:Excitatory Amino Acid Antagonists; D018733:Nicotinic Antagonists; D011619:Psychotropic Drugs; D018698:Glutamic Acid; D006247:Harmine; C020889:dihydrokainic acid; D009538:Nicotine; D003042:Cocaine; D007608:Kainic Acid